封面
市場調查報告書
商品編碼
1363144

重症監護診斷市場規模、佔有率、趨勢分析報告:按類型、最終用途、地區、細分市場趨勢,2023-2030 年

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency Rooms, Intensive Care Units), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 85 Pages | 商品交期: 2-10個工作天內

價格

重症監護診斷市場成長與趨勢:

Grand View Research, Inc. 的最新報告顯示,到 2030 年,全球重症監護診斷市場預計將達到 17.2 億美元。

預計2023年至2030年該市場將以4.9%的年複合成長率成長。支持該行業成長的關鍵要素是醫生和患者對這些測試的認知和認可迅速提高、老年人口和慢性疾病數量的增加、偏遠地區遠端醫療服務的採用以及技術的進步。 。分子診斷成本上升和技術純熟勞工短缺預計將成為限制該行業成長的要素。

依類型細分重症監護診斷市場,分為常規化學、特種化學、流式細胞儀、血液學、免疫蛋白、微生物學/感染疾病、血液凝固檢驗等。預計微生物和傳染病檢查和診斷領域的成長率最高,在預測期內年複合成長率將超過 5.5%。例如,醫療保健系統花費大量資源收集和處理血液培養物以進行病原體鑒定。

重症監護診斷測試(例如核酸增幅檢查)使臨床醫生能夠更快、更準確地檢測和鑒定細菌,盡快啟動適當的抗菌治療並消除可避免的藥物使用。為希望停止使用的臨床醫生提供指南。重症監護診斷市場依最終用途分為手術室、急診室和 ICU。在預測期內,急診室領域的成長率預計最高。

重症監護診斷市場報告亮點

  • 預計亞太地區在預測期內將以 6.9% 的年複合成長率成長最快。老年人口眾多、慢性病患病不斷上升、亞太地區專科醫院數量不斷增加以及農村地區醫療服務和基礎設施的改善是推動市場成長的要素。
  • 按類型分類的危重診斷市場佔有率來看,免疫蛋白診斷檢測領域預計將佔據最大佔有率。對快速、準確的預防性醫療服務的需求不斷成長是推動該市場成長的主要要素之一。
  • 截至最終用途,約 20% 的急診護理患者入住 ICU,約 58% 入住急診室。預計急診室在預測期內將以最高年複合成長率呈指數級成長。最近病患對急診服務的需求增加是由於急診室有能力為重症患者提供初步的急性護理診斷和治療。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 重症監護診斷市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 重症監護診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 重症監護診斷:類型估計/趨勢分析

  • 重症監護診斷市場:要點
  • 重症監護診斷市場:2022 年和 2030 年趨勢和市場佔有率分析
  • 常規和特種化學
  • 流式細胞儀
  • 血液學
  • 免疫蛋白
  • 微生物與感染疾病
  • 血液凝固檢驗
  • 其他

第5章 重症監護診斷:按最終用途的估計和趨勢分析

  • 重症監護診斷市場:要點
  • 重症監護診斷市場:2022 年和 2030 年趨勢和市場佔有率分析
  • 手術室
  • 加護病房
  • 急診室
  • 其他

第6章 重症監護診斷市場:區域估計與趨勢分析

  • 區域預測
  • 按地區分類的重症監護診斷市場:要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • BD
    • EKF Diagnostics
    • bioMerieux, Inc.
    • Siemens Healthcare Private Limited
    • Chembio Diagnostics, Inc.
    • Bayer AG
Product Code: GVR-1-68038-010-1

Critical Care Diagnostics Market Growth & Trends:

The global critical care diagnostics market size is expected to reach USD 1.72 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 4.9% from 2023 to 2030. The key factors supporting the industry's growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 5.5% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU's. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights:

  • The Asia Pacific region is expected to grow at the fastest CAGR of 6.9% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU's, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Critical Care Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Critical Care Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Critical Care Diagnostics: Type Estimates & Trend Analysis

  • 4.1. Critical Care Diagnostics Market: Key Takeaways
  • 4.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Routine and Special Chemistry
    • 4.3.1. Routine and special chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Flow Cytometry
    • 4.4.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Hematology
    • 4.5.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Immunoproteins
    • 4.6.1. Immunoproteins market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Microbial and Infectious Disease
    • 4.7.1. Microbial and infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Coagulation Testing
    • 4.8.1. Coagulation testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Critical Care Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Critical Care Diagnostics Market: Key Takeaways
  • 5.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Operation Room
    • 5.3.1. Operation room market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Intensive Care Unit
    • 5.4.1. Intensive care unit market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Emergency Rooms
    • 5.5.1. Emergency rooms market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Critical Care Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Critical Care Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Danaher
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. F. Hoffmann-La Roche Ltd
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. BD
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. EKF Diagnostics
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. bioMerieux, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Siemens Healthcare Private Limited
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Chembio Diagnostics, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Bayer AG
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 France critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 India critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait critical care diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Critical care diagnostics: Market outlook
  • Fig. 8 Critical care diagnostics: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Critical care diagnostics market driver impact
  • Fig. 14 Critical care diagnostics market restraint impact
  • Fig. 15 Critical care diagnostics market strategic initiatives analysis
  • Fig. 16 Critical care diagnostics market: Type movement analysis
  • Fig. 17 Critical care diagnostics market: Type outlook and key takeaways
  • Fig. 18 Routine and special chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Immunoproteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Microbial and infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Coagulation testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Critical care diagnostics market: End use movement analysis
  • Fig. 26 Critical care diagnostics market: End use outlook and key takeaways
  • Fig. 27 Operation room market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Intensive care unit market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Emergency rooms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global critical care diagnostics market: Regional movement analysis
  • Fig. 32 Global critical care diagnostics market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)